NovaBay Pharmaceuticals Inc (AMEX:NBY)
$ 0.759 -0.0211 (-2.7%) Market Cap: 3.71 Mil Enterprise Value: 5.22 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 41/100

NovaBay Pharmaceuticals Inc at Emerging Growth Virtual Conference Transcript

May 31, 2023 / 05:10PM GMT
Release Date Price: $22.75 (-0.17%)
Ana Berry
Berry Media, Inc - Moderator

Welcome back, everyone. Next up, we have NovaBay Pharmaceuticals. It trades on the New York Stock Exchange American under the symbol NBY.

NovaBay Pharmaceuticals develops and sells highly effective and scientifically proven products for the large growing eye care, skin care, and wound care markets. The company's leading eyecare product Avenova is the most prescribed anti-microbial lid and lash spray and is clinically proven as an effective solution to relieve chronic eye conditions, including dry eye.

So let's welcome the Chief Executive Officer, Justin Hall, to the Emerging Growth Conference. Nice to see you, Justin.

Justin Hall
NovaBay Pharmaceuticals, Inc. - CEO

Yeah, nice to see you, too, and thanks for having me.

Ana Berry
Berry Media, Inc - Moderator

All right. We look forward to hearing your presentation and call me back when you're ready for questions.

Justin Hall
NovaBay Pharmaceuticals, Inc. - CEO

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot